Efficacy of Noble Metal–alloy Endotracheal Tubes in Ventilator- associated Pneumonia Prevention: a Randomized Clinical Trial
Efficacy of Noble Metal–alloy Endotracheal Tubes in Ventilator- associated Pneumonia Prevention: a Randomized Clinical Trial
Background: Endotracheal tube (ETT) is an important risk factor for the development of Ventilator-associated pneumonia (VAP), as it acts as a reservoir for infectious microorganisms and bypasses the host’s defenses. One of the preventive measures for VAP is endotracheal tube composition. It has been reported that biofilm formation is reduced by using ETTs coated with pure silver or silver compounds. However, noble metal-alloy ETTs have not been adequately studied. Aims: To evaluate the efficacy of noble metal alloy ETT (coated Bactiguard Infection Protection ETTs) in preventing VAP compared to standard non-coated ETTs in patients requiring ≥ 48 hours of mechanical ventilation and presenting for coma due to drug intoxication. Study Design: Randomized controlled study. Methods: Participants were randomized using sealed envelopes with a concealed 1:1 allocation to either the intervention group or the control group. The intervention group used a noble metal–alloy ETT, while the control group received standard ETT. The primary outcomes were the incidence of VAP (per ventilated patients) and the duration of mechanical ventilation. Results: Initially, a total of 188 patients were assessed for eligibility, and the final allocation group consisted of 180 patients, who were subsequently randomized into the intervention group (n = 97) and control group (n = 83). The incidence of VAP in the intervention and control groups was 27.83% and 43.16% (P = 0.03), and the VAP ratio per 1000 ventilation days was 51.26/1000 and 83.38/1000 (P = 0.01), respectively. The mean durations of mechanical ventilation were 3.2 ± 0.78 in the intervention group and 5.03 ± 1.88 in the control group (P = 0.22). There was no statistically significant difference between groups in terms of mortality and duration of hospital stay. Conclusion: Noble metal-alloy ETT reduces the incidence of VAP, ventilation days, and ICU stay for patients in mechanical ventilation.
___
- 1. Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clinical Microbiol Rev. 2006;19:637-657. [CrossRef]
- 2. Buczko W. Ventilator-associated pneumonia among elderly Medicare beneficiaries in long-term care hospitals. Health Care Financ Rev. 2009;31:1-10. [CrossRef]
- 3. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867-903. [CrossRef]
- 4. Fernandez JF, Levine SM, Restrepo MI. Technologic advances in endotracheal tubes for prevention of ventilator-associated pneumonia. Chest. 2012;142:231-238. [CrossRef]
- 5. Koerner RJ. Contribution of endotracheal tubes to the pathogenesis of ventilator- associated pneumonia. J Hosp Infect. 1997;35:83-89. [CrossRef]
- 6. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA. 2008;300:805-813. [CrossRef]
- 7. Rello J, Kollef M, Diaz E, et al. Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study. Crit Care Med. 2006;34:2766-2772. [CrossRef]
- 8. Berra L, Kolobow T, Laquerriere P, et al. Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial. Intensive Care Med. 2008;34:1030-1037. [CrossRef]
- 9. Björling G, Johansson D, Bergström L, et al. Tolerability and performance of BIP endotracheal tubes with noble metal alloy coating--a randomized clinical evaluation study. BMC Anesthesiol. 2015;15:174. [CrossRef]
- 10. Lorente L, Lecuona M, Jim ́enez A, Mora ML, Sierra A. Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am J Respir Crit Care Med. 2007;176:1079-1083. [CrossRef]
- 11. Camargo LFA, De Marco FV, Barbas CSV, et al. Ventilator associated pneumonia: comparison between quantitative and qualitative cultures of tracheal aspirates. Crit Care. 2004;8:R422-430. [CrossRef]
- 12. Mietto C, Pinciroli R, Patel N, Berra L. Ventilator associated pneumonia: Evolving definitions and preventive strategies. Respir Care. 2013;58:990-1007. [CrossRef]
- 13. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-332. [CrossRef]
- 14. Rouzé A, Martin-Loeches I, Nseir S. Improved endotracheal tubes for prevention of ventilator-associated pneumonia: Better than silver and gold? Respir Care. 2019;64:108-109. [CrossRef]
- 15. Bologna RA, Tu LM, Polansky M, Fraimow HD, Gordon DA, Whitmore KE. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology. 1999;54:982-987. [CrossRef]
- 16. Berra L, De Marchi L, Yu ZX, Laquerriere P, Baccarelli A, Kolobow T. Endotracheal tubes coated with antiseptics decrease bacterial colonization of the ventilator circuits, lungs, and endotracheal tube. Anesthesiology. 2004;100:1446-1456. [CrossRef]
- 17. Berra L, Kolobow T, Laquerriere P, et al. Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial. Intensive Care Med. 2008;34:1030-1037. [CrossRef]
- 18. Gadani H, Vyas A, Kar AK. A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention. Indian J Anaesth. 2010;54:535-540. [CrossRef]
- 19. Kollef MH, Afessa B, Anzueto A, et al. NASCENT Investigation Group Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA. 2008;300:805-813. [CrossRef]
- 20. Becheanu CA, Tincu IF, Smadeanu RE, et al. Benefits of oligofructose and inuline in management of functional diarrhoea in children – interventional study. Farmacia. 2019;67:511-516. [CrossRef]
- 21. Schweiger J, Karlnoski R, Mangar D, et al. Impact of a low-pressure polyurethane adult endotracheal tube on the incidence of ventilator-associated pneumonia: A before and after concurrence study. ISRN Critical Care. 2013;13:1-6. [CrossRef]